跳至主要内容
临床试验/IRCT20180222038825N1
IRCT20180222038825N1招募中3 期

Comparison of the efficacy of topical Mometasone 0.1% and topical Hydrocortisone 1% and placebo in the prevention of acute radiation dermatitis in breast cancer patients

Esfahan University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Patients with breast cancer who had breast conservative surgery and should undergo breast radiation as adjuvant treatment

排除标准

  • Past history of skin disease like eczema and psoriasis
  • Past history of connective tissue disease like lupus erythematosus and sclerodermia
  • recurrent or metastatic breast cancer
  • Past radiation to the skin of treatment field

研究者

相似试验